Focus and Scope

Jurnal Kesehatan is open access, a peer-reviewed journal and authoritative source of health information. The journal has a special focus on Public health, nursing, midwifery, and relevant topics of health issues. The scopes of Jurnal Kesehatan are :

Public health: Epidemiology, Health promotion, health policies and systems, environmental, health information,

Nursing: Neurologist, paediatrics, community and home care, gerontology, maternity, medical and surgical nursing, psychiatric mental health

Midwifery: midwifery in complementary based, midwifery in community with gender-based.

Section Policies

Artikel

Open Submissions

Indexed

Peer Reviewed

Peer Review Process

Jurnal Kesehatan uses an online submission and review system. The submission and peer review of every article must be managed using this system and based on following Peer Review Policy.

• Jurnal Kesehatan Editorial Board is responsible for the selection of papers and the selection of reviewers.
• Articles must typically be reviewed by at least two independent reviewers.
• Reviewers are unaware of the identity of the authors, and authors are also unaware of the identity of reviewers (double-blind review)
• Reviewing process will consider novelty, objectivity, method, scientific impact, conclusion, and references.
• The final decision of manuscript acceptance shall be made by the Editorial Board according to reviewers critical comments.
• Jurnal Kesehatan Editorial Board shall protect the confidentiality of all material submitted to the journal and all communications with reviewers.

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Originality

All articles submitted to Jurnal Kesehatan must be original; the work, or large parts of it, must not have been published previously or be currently under consideration or review elsewhere. If there is any significant overlap with another paper, this must be cited in the article and mentioned on submission. Jurnal Kesehatan uses Crossref’s similarity checker (iThenticate) to check for plagiarism in articles; if clear plagiarism (including self-plagiarism) is identified, the article will be rejected.

Publication Criteria and Authorship

Competing Interests

Publication Ethics

Jurnal Kesehatan adheres to the COPE guidelines relating to ethical oversight.

Research involving humans

All studies involving humans (individuals, human data or material) must have been conducted according to the principles expressed in the Declaration of Helsinki. Approval must have been obtained for all protocols from the authors’ institutional or other relevant ethics committee (Institutional Review Board, IRB) to ensure that they meet national and international guidelines. Details of this approval must be provided when submitting an article, including the institution, review board name, and permit number(s).

Human studies categorized by race/ethnicity, age, disease/disabilities, religion, sex/gender, sexual orientation, or other socially constructed groupings, should include a justification of the choice of definitions and categories, including whether any rules of human categorization were required by the relevant funding agencies. Appropriate non-stigmatizing language should be used when describing different groups.

Ethics approval must be obtained before the research is conducted; retrospective approval can usually not be obtained and it may not be possible to publish the study.

 

As stated in the Recommendations of the International Committee of Medical Journal Editors: “Patients have a right to privacy that should not be infringed without informed consent. Identifying information should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that the patient be shown the manuscript to be published. When informed consent has been obtained it should be indicated in the published article.”

Consent to participate: For all studies involving human participants, including personal genomics studies, case reports, clinical trials, questionnaires, observations etc, informed written consent to take part in the research must have been obtained, and this should be stated in the article in a section entitled ‘Consent’. If only oral consent was obtained (rather than written), the reasons need to be explained, confirmation of IRB approval that oral consent was adequate must be provided, and a statement of how it was documented included in the Consent section.

Consent for publication of identifiable data: For any articles that include information that could potentially identify an individual, please ensure that you have obtained written, informed consent from all patients or healthy participants (or their legal guardians for minors, or next of kin if the participant is deceased), confirming that the results and any accompanying images can be published. This includes large clinical datasets with direct or indirect identifiers (see this article for information), specific details about individuals, images and so on.

If your article contains any identifiable images of individuals, you must include a statement confirming that you have permission to publish these images. If your article contains any clinical images or identifiable data then you must include an explicit consent statement under a separate heading of the ‘Consent’ section (we suggest: “We confirm that we have obtained permission to use [images/data] from the participants/patients/individuals included in this presentation”). Please also state the conditions under which the permission was obtained.

Alternatively, if no consent for publication was required (e.g. the data has been anonymised), then this should be clearly stated and a note should be added confirming that such alterations have not distorted scientific meaning.

Signed consent forms should be made available to the Jurnal Kesehatan editorial office if requested.

 

Research involving animals

Authors describing studies involving animals must have consulted the ‘Animal Research: Reporting In Vivo Experiments’ (ARRIVE) 2.0 guidelines, developed by the NC3Rs to improve standards of reporting, ensuring that the data from animal experiments can be fully scrutinized and utilized. Articles reporting in vivo experiments must adhere to the ARRIVE Essential 10 checklist as a minimum, and we encourage authors to use the full ARRIVE 2.0 checklist. The relevant information outlined in these guidelines should be included in the appropriate section of the article.

Experiments involving vertebrates or regulated invertebrates must be carried out within the ethical guidelines provided by the authors’ institution and national or international regulations. Where applicable, a statement of ethics permission granted or animal licenses should be included. If animals were used but ethical approval was not required, a clear statement should be included stating why this approval was unnecessary.

In all cases, a statement should be made to confirm that all efforts were made to ameliorate any suffering of animals and details of how this was achieved should be provided.

Authors should comply with the Convention on Biological Diversity and the Convention on the Trade in Endangered Species of Wild Fauna and Flora.

 

Research involving plants

Studies on plants must be carried out within the guidelines provided by the authors’ institution and national or international regulations. Where applicable, a statement of permissions granted or licenses should be included. Authors should comply with the Convention on Biological Diversity and the Convention on the Trade in Endangered Species of Wild Fauna and Flora.

Registration of Trials and Systematic Reviews, Meta-Analysis

Trial registration

Jurnal Kesehatan uses the WHO definition of a clinical trial to decide what constitutes a clinical trial:

“A clinical trial is any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Interventions include (but are not restricted to) drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioural treatments, process-of-care changes, preventive care, etc”.

Trials should be registered prospectively and the trial registration number and registration date must be included in the article. Further information can be found at the ICMJE faq on trial registration and the WHO provides a list of approved registries.

Although we expect trials to be registered before patient recruitment starts, several initiatives (such as the AllTrials campaign) have recognized that retrospective trial registration will encourage publication of both positive and negative results, and trials that were conducted before registration were possible. In line with these initiatives, F1000Research will consider retrospectively registered trials, provided an explanation for the late registration is provided in the article. Again, the trial registration number and date of registration must be included in the Methods section of the article.

Systematic Reviews and Meta-Analysis Registration

We encourage authors to register their systematic reviews and Meta-Analysis in PROSPERO or another registry for systematic reviews and Meta-Analysis. The registration number should be included in the article.

 

 

ISSN: 2657-1366